Glenmark has got the approval to manufacture and market Favipiravir in India for mild to moderate COVID-19 cases. It can be used for COVID-19 positive patients with co-morbid conditions such as diabetes and heart disease. The price of the medicine is 103 rupees per tablet, and will be available as a 200 mg tablet.
Visit this link to learn more. https://www.livemint.com/companies/news/glenmark-launches-new-coronavirus-medicine-at-103-per-tablet-10-things-to-know-11592715262785.html